Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Corteva | CTVA | 18. nov 2024 | 56.99 | +3.22 |
CorVel | CRVL | 18. nov 2024 | 355.98 | +3.26 |
Corvus Pharmaceuticals | CRVS | 18. nov 2024 | 8.34 | +1.83 |
Cosan ADR | CSAN | 18. nov 2024 | 7.73 | -1.65 |
COSCIENS Biopharma | CSCI | 18. nov 2024 | 3.20 | -0.88 |
Cosmos Health | COSM | 18. nov 2024 | 0.70 | +11.13 |
Costamare | CMRE | 18. nov 2024 | 14.65 | +1.81 |
Costamare Pref B | CMRE-B | 18. nov 2024 | 25.55 | -0.39 |
Costamare Pref C | CMRE-C | 18. nov 2024 | 26.20 | +0.08 |
Costamare Pref D | CMRE-D | 18. nov 2024 | 26.65 | -0.17 |
CoStar Group | CSGP | 18. nov 2024 | 73.35 | +2.95 |
Costco Wholesale | COST | 18. nov 2024 | 919.51 | +1.37 |
Coterra Energy | CTRA | 18. nov 2024 | 26.12 | +2.11 |
Coty A | COTY | 18. nov 2024 | 7.07 | -1.81 |
Couchbase | BASE | 18. nov 2024 | 19.64 | +2.03 |
Coupang A | CPNG | 18. nov 2024 | 24.36 | -0.49 |
Coursera | COUR | 18. nov 2024 | 6.87 | -0.87 |
Cousins Properties | CUZ | 18. nov 2024 | 30.81 | +0.52 |
Covenant Logistics Group | CVLG | 18. nov 2024 | 57.24 | -1.04 |
Coya Therapeutics | COYA | 18. nov 2024 | 6.07 | -3.96 |
CPS Technologies | CPSH | 18. nov 2024 | 1.41 | +0.71 |
CRA International | CRAI | 18. nov 2024 | 186.62 | +0.19 |
Cracker Barrel Old Country Store | CBRL | 18. nov 2024 | 48.42 | -0.80 |
Crane Company | CR | 18. nov 2024 | 171.21 | -1.32 |
Crane NXT | CXT | 18. nov 2024 | 56.03 | +0.97 |
Crawford & Company A | CRD-A | 18. nov 2024 | 11.66 | +0.09 |
Crawford & Company B | CRD-B | 18. nov 2024 | 11.46 | -1.72 |
Creative Media & Community Trust | CMCT | 18. nov 2024 | 0.26 | -6.94 |
Creative Medical Technology | CELZ | 18. nov 2024 | 2.50 | -7.41 |
Creative Realities | CREX | 18. nov 2024 | 3.39 | -3.97 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.